29650 Federal Register / Vol. 61, No. 114 / Wednesday, June 12, 1996 / Rules and Regulations

labeling requirement under the CPSA,

FHSA, or FFA, in accordance with

provisions of 16 CFR 1009.9. (These

products remain subject to the

notification requirements of subpart A

of this part 1019.)

(6) Products which fail to comply

with an applicable standard of

flammability issued under provisions of

the Flammable Fabrics Act (15 U.S.C.

1191 et seq.). The Commission’s policy

regarding export of such products is set

forth in the Commission’s Memorandum

Decision and Order In the Matter of

Imperial Carpet Mills, Inc., CPSC Docket

No. 80–2, July 7, 1983, and allows

export without regard to whether the

products have been distributed in

domestic commerce. (See section 15 of

the Flammable Fabrics Act, 15 U.S.C.

1202, and subpart A of this part 1019 for

requirements governing export of such

products.)

§ 1019.32 Statutory provisions.

(a) Section 18(a) of the Consumer

Product Safety Act (15 U.S.C. 2057(a))

states:

This Act [the Consumer Product Safety

Act] shall not apply to any consumer product

if: (1) It can be shown that such product is

manufactured, sold, or held for sale for

export from the United States (or that such

product was imported for export), unless (A)

such consumer product is in fact distributed

in commerce for use in the United States, or

(B) the Commission determines that

exportation of such product presents an

unreasonable risk of injury to consumers

within the United States, and (2) such

consumer product when distributed in

commerce, or any container in which it is

enclosed when so distributed, bears a stamp

or label stating that such consumer product

is intended for export; except that this Act

shall apply to any consumer product

manufactured for sale, offered for sale, or

sold for shipment to any installation of the

United States located outside of the United

States.

(b) Section 4 of the Federal Hazardous

Substances Act (15 U.S.C. 1263) states

in part:

The following acts and the causing thereof

are hereby prohibited: (a) The introduction or

delivery for introduction into interstate

commerce of any misbranded hazardous

substance or banned hazardous substance.

* * * (c) The receipt in interstate commerce

of any misbranded hazardous substance or

banned hazardous substance and the delivery

or proffered delivery thereof for pay or

otherwise.

(c) Section 5(b) of the Federal

Hazardous Substances Act (15 U.S.C.

1264(b)) provides in part:

No person shall be subject to the penalties

of this section * * * (3) for having violated

subsection (a) or (c) of section 4 with respect

to any hazardous substance shipped or

delivered for shipment for export to any

foreign country, in a package marked for

export on the outside of the shipping

container and labeled in accordance with the

specifications of the foreign purchaser and in

accordance with the laws of the foreign

country, but if such hazardous substance is

sold or offered for sale in domestic

commerce, or if the Consumer Product Safety

Commission determines that exportation of

such substance presents an unreasonable risk

of injury to persons residing within the

United States, this clause shall not apply.

§ 1019.33 Statement of policy and

interpretation.

(a) In its enforcement of the Consumer

Product Safety Act, the Commission

interprets the provisions of that Act to

prohibit the export of products which

fail to comply with an applicable

consumer product safety standard or

banning rule issued under that Act if

those products have at any time been

distributed in commerce for use in the

United States.

(b) In its enforcement of the Federal

Hazardous Substances Act, the

Commission interprets the provisions of

the Act to prohibit the export of

products which are misbranded

substances or banned hazardous

substances as those terms are used in

that Act if those products have at any

time been sold or offered for sale in

domestic commerce.

Dated: June 6, 1996.

Sadye E. Dunn,

Secretary, Consumer Product Safety

Commission.

[FR Doc. 96–14760 Filed 6–11–96; 8:45 am]

BILLING CODE 6355–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

21 CFR Part 189

[Docket No. 91N–0326]

RIN 0910–AA06

Tin-Coated Lead Foil Capsules for

Wine Bottles; Correction

AGENCY: Food and Drug Administration,

HHS.

ACTION: Final rule; correction.

SUMMARY: The Food and Drug

Administration (FDA) is correcting a

final rule that appeared in the Federal

Register of February 8, 1996 (61 FR

4816). The document announced that

FDA was amending its regulations to

prohibit the use of tin-coated lead foil

capsules on wine bottles. The document

was published with some inadvertent

errors. This document corrects those

errors.

EFFECTIVE DATE: February 8, 1996.

FOR FURTHER INFORMATION CONTACT:

Cristina R. Ford, Center for Food Safety

and Applied Nutrition (HFS–726), Food

and Drug Administration, 200 C St. SW.,

Washington, DC 20204, 202–205–5268.

In FR Doc. 96–2665, appearing on

page 4816 in the Federal Register of

Thursday, February 8, 1996, the

following corrections are made:

1. On page 4819, in the second

column, in the seventh line, ‘‘$4.6

million’’ is corrected to read ‘‘$0.4

million’’ and in the same column, in the

first full paragraph, in the fourth line,

‘‘$5.7 million’’ is corrected to read ‘‘$0.8

million.’’

2. On page 4819, in the text at the

bottom of the page, below Table 2, in

the third column, beginning in the

second line, ‘‘$97,000 to $8.7 million’’

is corrected to read ‘‘$111,000 to $3.8

million.’’

Dated: June 5, 1996.

William K. Hubbard,

Associate Commisssioner for Policy

Coordination.

[FR Doc. 96–14891 Filed 6–11–96; 8:45 am]

BILLING CODE 4160–01–F

21 CFR Part 520

Oral Dosage Form New Animal Drugs;

Praziquantel, Pyrantel Pamoate, and

Febantel Tablets

AGENCY: Food and Drug Administration,

HHS.

ACTION: Final rule.

SUMMARY: The Food and Drug

Administration (FDA) is amending the

animal drug regulations to reflect

approval of a supplemental new animal

drug application (NADA) filed by Bayer

Corp., Agriculture Div., Animal Health

Products. The supplement provides for

oral prescription use of Drontal PlusTM

for removal and control of the tapeworm

Echinococcus multilocularis in dogs.

EFFECTIVE DATE: June 12, 1996.

FOR FURTHER INFORMATION CONTACT:

Sandra K. Woods, Center for Veterinary

Medicine (HFV–114), Food and Drug

Administration, 7500 Standish Pl.,

Rockville, MD 20855, 301–594–0614.

SUPPLEMENTARY INFORMATION: Bayer

Corp., Agriculture Div., Animal Health

Products, P.O. Box 390, Shawnee

Mission, KS 66201, filed supplemental

NADA 141–007, which provides for oral

prescription use of Drontal PlusTM tablet

for small dogs containing 22.7

milligrams (mg) praziquantel, 22.7 mg

pyrantel base (as pyrantel pamoate), and